Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

The Lancet - Tập 358 - Trang 527-533 - 2001
Shamir R Mehta1, Salim Yusuf1, Ron JG Peters2, Michel E Bertrand1, Basil S Lewis3, Madhu K Natarajan1, Klas Malmberg4, Hans-Jürgen Rupprecht5, Feng Zhao1, Susan Chrolavicius1, Ingrid Copland1, Keith AA Fox6
1Division of Cardiology, the Population Health Research Institute and the Canadian Cardiovascular Collaboration Project Office, McMaster University, Hamilton, Canada
2Academic Medical Center, Amsterdam, Netherlands
3Department of Cardiology, Hôpital Cardiologique, Lille, France
4Lady Davis Carmel Hospital, Haifa, Israel
5Karolinska Hospital, Stockholm, Sweden
6Klinikum der Johannes-Gutenberg-Universität, Mainz, Germany and Royal Infirmary of Edinburgh, UK

Tài liệu tham khảo

Smith, 2001, J Am Coll Cardiol, 37, 2239i, 10.1016/S0735-1097(01)01345-6 Popma, 2001, Antiplatelet therapy in patients undergoing percutaneous coronary intervention, Chest, 119, 321S, 10.1378/chest.119.1_suppl.321S Schwartz, 1988, Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty, N Engl J Med, 318, 1714, 10.1056/NEJM198806303182603 Barnathan, 1987, Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty, Circulation, 76, 125, 10.1161/01.CIR.76.1.125 Kong, 1998, Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease, Circulation, 98, 2829, 10.1161/01.CIR.98.25.2829 Fuster, 1992, The pathogenesis of coronary artery disease and the acute coronary syndromes, N Engl J Med, 326, 242, 10.1056/NEJM199201233260406 Topol, 1998, Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence, Circulation, 97, 211, 10.1161/01.CIR.97.2.211 Van Langenhove, 2000, Distal embolization: a threat to the coronary artery?, Circulation, 102, E95, 10.1161/01.CIR.102.13.e95 Webb, 1999, Retrieval and analysis of particulate debris after saphenous vein graft intervention, J Am Coll Cardiol, 34, 468, 10.1016/S0735-1097(99)00196-5 Savage, 1995, Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty: Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II), Circulation, 92, 3194, 10.1161/01.CIR.92.11.3194 van Domburg, 2001, Long-term clinical outcome after coronary balloon angioplasty: identification of a population at low risk of recurrent events during 17 years of follow-up, Eur Heart J, 22, 934, 10.1053/euhj.2000.2420 O'Neill, 2000, Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization: Evaluation of Oral Xemilofiban in Controlling Thrombotic Events, N Engl J Med, 342, 1316, 10.1056/NEJM200005043421803 Hannan, 2000, A comparison of short- and long-term outcomes for balloon angioplasty and coronary stent placement, J Am Coll Cardiol, 36, 395, 10.1016/S0735-1097(00)00752-X 2000, Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial, Lancet, 356, 2037, 10.1016/S0140-6736(00)03400-0 Chew, 2001, Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials, Circulation, 103, 201, 10.1161/01.CIR.103.2.201 Bossavy, 1998, A double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans, Blood, 92, 1518, 10.1182/blood.V92.5.1518 Herbert, 1998, The antiaggregating and antithrombotic activity of clopidrogrel is potentiated by aspirin in several experimental models in the rabbit, Thromb Haemost, 80, 512, 10.1055/s-0037-1615238 Moshfegh, 2000, Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy, J Am Coll Cardiol, 36, 699, 10.1016/S0735-1097(00)00817-2 Mehta, 2000, The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programe: rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease, Eur Heart J, 21, 2033, 10.1053/euhj.2000.2474 Rosenbaum, 1991, Discussing hidden bias in observational studies, Ann Intern Med, 115, 901, 10.7326/0003-4819-115-11-901 Joffe, 1999, Propensity scores, Am J Epidemiol, 150, 327, 10.1093/oxfordjournals.aje.a010011 D'Agostino, 1998, Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group, Stat Med, 17, 2265, 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B Boersma, 1999, Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention, Circulation, 100, 2045, 10.1161/01.CIR.100.20.2045 Cannon, 2001, Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban, N Engl J Med, 344, 1939, 10.1056/NEJM200106213442501 Wallentin, 2000, Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial, Lancet, 356, 9, 10.1016/S0140-6736(00)02427-2 1994, Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients, BMJ, 308, 81, 10.1136/bmj.308.6921.81 ten Berg, 2000, Effect of coumarins started before coronary antioplasty on acute complications and long term follow-up: a randomised trial, Circulation, 102, 386, 10.1161/01.CIR.102.4.386 Sakatani, 1999, Intracoronary surface changes after Palmaz-Schatz stent implantation: serial observations with coronary angioscopy, Am Heart J, 138, 962, 10.1016/S0002-8703(99)70024-4 Grewe, 2000, Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen, J Am Coll Cardiol, 35, 157, 10.1016/S0735-1097(99)00486-6 Topol, 2001, Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary intervention, N Engl J Med, 344, 1888, 10.1056/NEJM200106213442502